|
Pharma R&D is the core power of pharma industry in the 21st century, especially when a nubmer of blockbuster drugs are going off-patent in the next five years. CROs take on 1/3 of the drug discovery work with grows of 20%-25% in the global pharma industry every year. The advantage of Chinese talent and costs as well as the increasing Asian pharma marketing raise Chinese CRO & CMO to an international level.
|
|
| ICSE China 2012, the best displaying platform for pharma CRO & CMO |
|
|
Under these opportunites, ICSE China, the only specialized contract services show in China, will be on staged on 26th to 28 to June 2012 at SNIEC, Shanghai, China. It is co-located with CPhI/P-MEC China – the most international pharma industry events in China. Join us, be part of the booming pharma outsourcing and contract services market in China and market your services to over 27,000 pharmaceutical professionals in world's largest emerging market!
>> Click here to book your stand now
|
|
|
|
|
|
|
|
| Custom Synthesis ︱ Biotrials ︱ Medicinal Chemistry ︱ Drug Metabolism & PK ︱ Preformulation & Formulation ︱ Pre-clinical Trials︱ Analytical Development ︱ Clinical Trials Phase 1 to IV ︱ New Drug Application ︱ Process Research & Development ︱ Formula Optimization ︱ API Synthesis ︱ Intermediate Synthesis ︱ Drug Manufacturing |
|
|
| 2012 Conferences and seminars |
|
|
High-end CRO & CMO forums will be held along with ICSE China 2012. World-renowed pharmaceutical companies, research institutes, senior experts and elites from CRO & CMO companies will be invited to discuss hot industry topics. The forums aim to pomote industrial development and technological innovation in China's future CRO & CMO industry, and will provide the participants with a platform to exchange technical experiences, disply research results as well as share market information.
|
|
|
|
